Cargando…

A decade of immune-checkpoint inhibitors in cancer therapy

Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.

Detalles Bibliográficos
Autor principal:	Robert, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393098/ https://www.ncbi.nlm.nih.gov/pubmed/32732879 http://dx.doi.org/10.1038/s41467-020-17670-y

Ejemplares similares

The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy
por: Sabio, Erich, et al.
Publicado: (2019)

Are we over-treating with checkpoint inhibitors?
por: Danson, Sarah, et al.
Publicado: (2019)

Deciphering the response and resistance to immune-checkpoint inhibitors in lung cancer with artificial intelligence-based analysis: when PIONeeR meets QUANTIC
por: Ciccolini, Joseph, et al.
Publicado: (2020)

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
por: Waissengrin, Barliz, et al.
Publicado: (2021)

Spotting trends in organocatalysis for the next decade
por: Lassaletta, José M.
Publicado: (2020)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
por: O’Donnell, Jake S., et al.
Publicado: (2016)

Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approach
por: Khan, Zia, et al.
Publicado: (2019)

Retrospective on a decade of machine learning for chemical discovery
por: von Lilienfeld, O. Anatole, et al.
Publicado: (2020)

The second decade of synthetic biology: 2010–2020
por: Meng, Fankang, et al.
Publicado: (2020)

Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
por: Wright, Jordan J., et al.
Publicado: (2018)

Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
por: Tan, Hui Zhuan, et al.
Publicado: (2023)

Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations
por: Perazella, Mark A, et al.
Publicado: (2021)

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
por: High, Katherine A.
Publicado: (2020)

Editorial Comment to A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Kijima, Toshiki
Publicado: (2021)

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
por: Pickles, Oliver J., et al.
Publicado: (2020)

A decade after the metabolomics standards initiative it's time for a revision
por: Spicer, Rachel A., et al.
Publicado: (2017)

A new view of the spindle checkpoint
por: Hoyt, M. Andrew
Publicado: (2001)

Much ado about nothing – a decade of porous materials research
por: Thomas, Arne
Publicado: (2020)

Editorial Comment to Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors
por: Yuasa, Takeshi
Publicado: (2019)

‘Prevention is better than cure’: warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury
por: Belliere, Julie, et al.
Publicado: (2022)

Immune checkpoint inhibitors in cancer therapy
por: Webb, Eika S., et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Nearly a decade on — trends, risk factors and policy implications in global obesity
por: Malik, Vasanti S., et al.
Publicado: (2020)

Unfinished business after five decades of ozone-layer science and policy
por: Solomon, Susan, et al.
Publicado: (2020)

Single atom catalysis: a decade of stunning progress and the promise for a bright future
por: Mitchell, Sharon, et al.
Publicado: (2020)

Revisiting the role of acute kidney injury in patients on immune checkpoint inhibitors: a good prognosis renal event with a significant impact on survival
por: García-Carro, Clara, et al.
Publicado: (2023)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
por: Basudan, Ahmed M.
Publicado: (2022)

Reaping what you sow: England's drastic reduction in childhood secondhand smoke exposure in two decades
por: Gallus, Silvano, et al.
Publicado: (2022)

Immunity and the coral crisis
por: Palmer, Caroline V.
Publicado: (2018)

Three decades of heart transplantation in the Netherlands
por: Pinto, Y. M.
Publicado: (2017)

How satellite InSAR has grown from opportunistic science to routine monitoring over the last decade
por: Biggs, Juliet, et al.
Publicado: (2020)

Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults
por: Dzankic, Paula Juricic, et al.
Publicado: (2021)

Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
por: Michielin, Olivier, et al.
Publicado: (2022)

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
por: Botticelli, Andrea, et al.
Publicado: (2017)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
por: Frankel, Arthur E., et al.
Publicado: (2019)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
por: Quilez, Alicia, et al.
Publicado: (2020)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hbn4co4pn55s7sprt8kge634mh